Anticonvulsant prophylaxis for brain tumor surgery: Determining the current best available evidence

Eli T. Sayegh, Shayan Fakurnejad, Taemin Oh, Orin Bloch, Andrew T. Parsa

Research output: Contribution to journalReview article

32 Citations (Scopus)

Abstract

Patients who undergo craniotomy for brain tumor resection are prone to experiencing seizures, which can have debilitating medical, neurological, and psychosocial effects. A controversial issue in neurosurgery is the common practice of administering perioperative anticonvulsant prophylaxis to these patients despite a paucity of supporting data in the literature. The foreseeable benefits of this strategy must be balanced against potential adverse effects and interactions with critical medications such as chemotherapeutic agents and corticosteroids. Multiple disparate metaanalyses have been published on this topic but have not been applied into clinical practice, and, instead, personal preference frequently determines practice patterns in this area of management. Therefore, to select the current best available evidence to guide clinical decision making, the literature was evaluated to identify meta-analyses that investigated the efficacy and/or safety of anticonvulsant prophylaxis in this patient population. Six meta-analyses published between 1996 and 2011 were included in the present study. The Quality of Reporting of Meta-analyses and Oxman-Guyatt methodological quality assessment tools were used to score these meta-analyses, and the Jadad decision algorithm was applied to determine the highest-quality meta-analysis. According to this analysis, 2 metaanalyses were deemed to be the current best available evidence, both of which conclude that prophylactic treatment does not improve seizure control in these patients. Therefore, this management strategy should not be routinely used.

Original languageEnglish (US)
Pages (from-to)1139-1147
Number of pages9
JournalJournal of Neurosurgery
Volume121
Issue number5
DOIs
StatePublished - Nov 2014
Externally publishedYes

Fingerprint

Brain Neoplasms
Anticonvulsants
Meta-Analysis
Seizures
Craniotomy
Neurosurgery
Adrenal Cortex Hormones
Safety
Population
Therapeutics

Keywords

  • Anticonvulsant
  • Antiepileptic
  • Brain tumors
  • Craniotomy
  • Epilepsy
  • Oncology
  • Prophylaxis

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Anticonvulsant prophylaxis for brain tumor surgery : Determining the current best available evidence. / Sayegh, Eli T.; Fakurnejad, Shayan; Oh, Taemin; Bloch, Orin; Parsa, Andrew T.

In: Journal of Neurosurgery, Vol. 121, No. 5, 11.2014, p. 1139-1147.

Research output: Contribution to journalReview article

Sayegh, Eli T. ; Fakurnejad, Shayan ; Oh, Taemin ; Bloch, Orin ; Parsa, Andrew T. / Anticonvulsant prophylaxis for brain tumor surgery : Determining the current best available evidence. In: Journal of Neurosurgery. 2014 ; Vol. 121, No. 5. pp. 1139-1147.
@article{db6dca4d84ef4cd48fb4e8a84cd07bad,
title = "Anticonvulsant prophylaxis for brain tumor surgery: Determining the current best available evidence",
abstract = "Patients who undergo craniotomy for brain tumor resection are prone to experiencing seizures, which can have debilitating medical, neurological, and psychosocial effects. A controversial issue in neurosurgery is the common practice of administering perioperative anticonvulsant prophylaxis to these patients despite a paucity of supporting data in the literature. The foreseeable benefits of this strategy must be balanced against potential adverse effects and interactions with critical medications such as chemotherapeutic agents and corticosteroids. Multiple disparate metaanalyses have been published on this topic but have not been applied into clinical practice, and, instead, personal preference frequently determines practice patterns in this area of management. Therefore, to select the current best available evidence to guide clinical decision making, the literature was evaluated to identify meta-analyses that investigated the efficacy and/or safety of anticonvulsant prophylaxis in this patient population. Six meta-analyses published between 1996 and 2011 were included in the present study. The Quality of Reporting of Meta-analyses and Oxman-Guyatt methodological quality assessment tools were used to score these meta-analyses, and the Jadad decision algorithm was applied to determine the highest-quality meta-analysis. According to this analysis, 2 metaanalyses were deemed to be the current best available evidence, both of which conclude that prophylactic treatment does not improve seizure control in these patients. Therefore, this management strategy should not be routinely used.",
keywords = "Anticonvulsant, Antiepileptic, Brain tumors, Craniotomy, Epilepsy, Oncology, Prophylaxis",
author = "Sayegh, {Eli T.} and Shayan Fakurnejad and Taemin Oh and Orin Bloch and Parsa, {Andrew T.}",
year = "2014",
month = "11",
doi = "10.3171/2014.7.JNS132829",
language = "English (US)",
volume = "121",
pages = "1139--1147",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "5",

}

TY - JOUR

T1 - Anticonvulsant prophylaxis for brain tumor surgery

T2 - Determining the current best available evidence

AU - Sayegh, Eli T.

AU - Fakurnejad, Shayan

AU - Oh, Taemin

AU - Bloch, Orin

AU - Parsa, Andrew T.

PY - 2014/11

Y1 - 2014/11

N2 - Patients who undergo craniotomy for brain tumor resection are prone to experiencing seizures, which can have debilitating medical, neurological, and psychosocial effects. A controversial issue in neurosurgery is the common practice of administering perioperative anticonvulsant prophylaxis to these patients despite a paucity of supporting data in the literature. The foreseeable benefits of this strategy must be balanced against potential adverse effects and interactions with critical medications such as chemotherapeutic agents and corticosteroids. Multiple disparate metaanalyses have been published on this topic but have not been applied into clinical practice, and, instead, personal preference frequently determines practice patterns in this area of management. Therefore, to select the current best available evidence to guide clinical decision making, the literature was evaluated to identify meta-analyses that investigated the efficacy and/or safety of anticonvulsant prophylaxis in this patient population. Six meta-analyses published between 1996 and 2011 were included in the present study. The Quality of Reporting of Meta-analyses and Oxman-Guyatt methodological quality assessment tools were used to score these meta-analyses, and the Jadad decision algorithm was applied to determine the highest-quality meta-analysis. According to this analysis, 2 metaanalyses were deemed to be the current best available evidence, both of which conclude that prophylactic treatment does not improve seizure control in these patients. Therefore, this management strategy should not be routinely used.

AB - Patients who undergo craniotomy for brain tumor resection are prone to experiencing seizures, which can have debilitating medical, neurological, and psychosocial effects. A controversial issue in neurosurgery is the common practice of administering perioperative anticonvulsant prophylaxis to these patients despite a paucity of supporting data in the literature. The foreseeable benefits of this strategy must be balanced against potential adverse effects and interactions with critical medications such as chemotherapeutic agents and corticosteroids. Multiple disparate metaanalyses have been published on this topic but have not been applied into clinical practice, and, instead, personal preference frequently determines practice patterns in this area of management. Therefore, to select the current best available evidence to guide clinical decision making, the literature was evaluated to identify meta-analyses that investigated the efficacy and/or safety of anticonvulsant prophylaxis in this patient population. Six meta-analyses published between 1996 and 2011 were included in the present study. The Quality of Reporting of Meta-analyses and Oxman-Guyatt methodological quality assessment tools were used to score these meta-analyses, and the Jadad decision algorithm was applied to determine the highest-quality meta-analysis. According to this analysis, 2 metaanalyses were deemed to be the current best available evidence, both of which conclude that prophylactic treatment does not improve seizure control in these patients. Therefore, this management strategy should not be routinely used.

KW - Anticonvulsant

KW - Antiepileptic

KW - Brain tumors

KW - Craniotomy

KW - Epilepsy

KW - Oncology

KW - Prophylaxis

UR - http://www.scopus.com/inward/record.url?scp=84922392686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922392686&partnerID=8YFLogxK

U2 - 10.3171/2014.7.JNS132829

DO - 10.3171/2014.7.JNS132829

M3 - Review article

C2 - 25170671

AN - SCOPUS:84922392686

VL - 121

SP - 1139

EP - 1147

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 5

ER -